MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an update in relation to the financing agreement entered into with Mackie Research Capital Corporation.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released a corporate update in regards to a financing agreement entered into with Mackie Research Capital Corporation.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an operational update on its horticultural division United Greeneries Ltd.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by MMJ's wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Ltd have been published.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an operational update on its medical and health division Satipharm AG.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that it has agreed to invest A$500,000 in ASX listed Israeli life sciences company eSense-Lab Limited (ASX:ESE).
MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 30 September 2017, together with its Appendix 4C.
